We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is ...

A shortage of intravenous and injectable saline solutions in the United States has now been resolved, U.S. Food and Drug ...

Fintel reports that on August 4, 2025, Stifel downgraded their outlook for Baxter International (NYSE:BAX) from Buy to Hold. Analyst Price Forecast Suggests 72.35% Upside As of July 17, 2025, the ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Baxter International Inc. ( NYSE: BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025.

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.